As Germany continues to make strides in the cannabis industry, new details of German Health Minister Jens Spahn’s cannabis legalization plan have recently surfaced.
The plan, which was announced in November 2019, is aimed at allowing the use of cannabis for medical purposes in Germany. The plan would legalize the use of cannabis for medical purposes and provide access to cannabis for patients with certain medical conditions.
The new details of the plan include the creation of a new agency, the German Cannabis Agency, which would be responsible for licensing and regulating the cultivation, production, and distribution of medical cannabis in Germany. The agency would be responsible for setting up a system to ensure that only cannabis products of the highest quality are available to patients.
In addition, the plan would create a system for the prescription of cannabis products, as well as a system for the reimbursement of medical cannabis by health insurance companies.
The plan also includes provisions for the research and development of new cannabis-based medicines. The research would be conducted by universities and research institutes, with the results being made available to the public.
The plan has been met with both support and criticism from various groups. Supporters argue that it would provide access to medical cannabis for those who need it, while critics argue that the plan could lead to an increase in recreational cannabis use.
The plan is still in the early stages and is expected to be finalized later this year. If the plan is approved, it could have a major impact on the cannabis industry in Germany, providing access to medical cannabis to those who need it, as well as creating new opportunities for research and development.